data_2xbd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2xbd _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.49 ' O ' ' CG2' ' A' ' 247' ' ' THR . 97.8 m . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.519 -0.549 . . . . 4.79 109.519 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -136.14 145.47 17.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.527 -1.429 . . . . 2.16 109.527 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 11.6 p -109.77 170.2 8.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.264 -1.139 . . . . 0.94 109.473 179.988 52.279 134.376 -93.017 104.192 2.02 104.194 -115.654 169.863 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.455 ' O ' HG21 ' A' ' 269' ' ' VAL . 0.0 OUTLIER -149.28 175.02 11.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 1.68 109.656 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -132.8 117.02 28.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.785 -0.766 . . . . 1.08 109.577 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.12 115.1 27.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 1.31 109.429 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.509 ' HB1' ' CE2' ' A' ' 267' ' ' TYR . . . -108.14 128.89 55.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 1.15 109.454 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 160.58 29.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 1.65 109.47 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -100.49 120.86 40.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 2.57 109.502 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -92.05 -80.56 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 1.29 109.485 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -103.31 145.05 30.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.228 -0.92 . . . . 2.01 109.476 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -125.98 127.11 45.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 2.46 109.448 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -110.43 -170.78 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 1.24 109.477 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 13.5 m -100.74 3.17 42.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 2.05 109.537 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 262' ' ' ARG . 5.3 p-10 -133.86 7.3 3.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.915 . . . . 1.58 109.514 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 261' ' ' ASP . 29.2 ptt180 174.8 170.15 0.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.905 . . . . 2.6 109.448 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.542 ' CE2' HG21 ' A' ' 325' ' ' THR . 51.9 p90 -144.39 134.02 23.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 2.14 109.453 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -80.0 154.86 27.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.83 109.464 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.509 ' CG1' ' CE1' ' A' ' 267' ' ' TYR . 3.3 t -133.86 155.38 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 1.06 109.536 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 3.4 m -126.2 93.14 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 1.15 109.437 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' TYR . . . . . 0.509 ' CE2' ' HB1' ' A' ' 253' ' ' ALA . 54.7 m-85 -91.44 136.22 33.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 2.2 109.486 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 99.5 p -147.26 162.41 38.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 1.64 109.519 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.496 HG11 ' N ' ' A' ' 270' ' ' SER . 94.6 t -145.92 145.71 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 1.17 109.482 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.496 ' N ' HG11 ' A' ' 269' ' ' VAL . 0.0 OUTLIER -118.14 -173.52 2.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 1.87 109.438 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.411 ' O ' ' OG ' ' A' ' 272' ' ' SER . . . 87.5 -40.82 3.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.543 -1.423 . . . . 0.79 109.543 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 271' ' ' GLY . 4.2 m -175.32 170.79 3.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -1.144 . . . . 1.82 109.441 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.5 p -101.88 -21.61 14.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 1.75 109.522 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.78 75.89 6.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 1.19 109.004 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.638 ' CZ3' ' CG2' ' A' ' 277' ' ' VAL . 10.2 p-90 -128.53 170.89 12.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.44 109.656 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 5.0 m -122.61 99.98 6.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 1.24 109.232 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.638 ' CG2' ' CZ3' ' A' ' 275' ' ' TRP . 40.8 t -79.91 132.15 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 1.44 109.67 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 4.5 m-20 -124.35 114.94 20.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 1.91 109.232 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 21.1 mt -90.49 145.52 24.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 1.22 109.589 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -133.95 76.53 1.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 1.09 109.388 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 326' ' ' PRO . 23.8 mt -59.9 168.81 1.66 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.928 . . . . 1.78 109.595 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -122.29 144.44 48.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 2.01 109.417 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.5 -114.92 3.94 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.553 -1.419 . . . . 1.48 109.553 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.82 18.5 3.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -1.113 . . . . 2.26 109.498 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.501 ' NE2' ' HB3' ' A' ' 322' ' ' SER . 68.1 mt-30 -50.18 153.18 1.51 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 1.63 109.443 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 285' ' ' GLN . 44.9 p -140.84 165.66 26.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 1.22 109.496 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 16.8 mt -112.77 144.54 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 1.6 109.456 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.23 7.16 3.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 3.32 109.547 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.454 ' HB2' ' OG1' ' A' ' 316' ' ' THR . . . -151.57 152.67 33.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.925 . . . . 1.23 109.472 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 10.0 p -168.84 121.29 0.79 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 1.54 109.448 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.573 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 33.5 p90 -129.91 144.62 51.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.6 109.493 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 291' ' ' TRP . 0.3 OUTLIER 75.54 13.75 2.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 2.01 109.458 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.44 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . 177.79 149.94 0.19 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.299 -0.876 . . . . 1.13 109.459 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -101.34 118.33 36.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 1.21 109.521 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.57 97.34 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 1.28 109.476 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 34.6 p -127.94 159.32 35.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 1.82 109.452 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 150.08 -174.02 29.62 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 1.81 109.545 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.62 163.92 37.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -1.179 . . . . 3.75 109.474 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 92.05 -153.02 21.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.557 -1.417 . . . . 3.06 109.557 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 52.7 m -92.32 9.45 33.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -1.149 . . . . 2.4 109.484 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.1 p -127.23 161.33 28.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 1.54 109.445 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.07 128.6 28.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.888 . . . . 2.78 109.465 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.4 m -86.39 143.71 27.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 1.33 109.49 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.458 ' HB ' ' HB ' ' A' ' 277' ' ' VAL . 77.3 t -134.24 135.57 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 1.16 109.454 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 306' ' ' PRO . 72.7 p -139.56 157.3 70.53 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 1.36 109.461 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 305' ' ' THR . 35.6 Cg_endo -77.99 153.48 28.93 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.742 2.295 . . . . 0.81 110.43 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -122.04 17.33 10.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 1.59 109.501 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 85.3 44.07 6.36 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.56 -1.416 . . . . 1.58 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -49.13 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -1.165 . . . . 2.55 109.475 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 178.64 -165.63 34.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.566 -1.413 . . . . 1.7 109.566 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -115.94 10.0 15.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -1.146 . . . . 1.68 109.428 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 23.4 m -120.75 109.68 15.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 1.21 109.47 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.482 ' CB ' ' HB3' ' A' ' 292' ' ' ASN . 38.9 p90 -127.03 160.53 30.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 2.25 109.485 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.573 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -124.37 157.61 18.74 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.548 -1.421 . . . . 0.34 109.548 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.437 ' O ' HG21 ' A' ' 315' ' ' VAL . 17.3 m -139.19 148.69 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -1.137 . . . . 1.09 109.426 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 289' ' ' ALA . 99.0 m -106.76 115.61 30.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 1.2 109.501 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.506 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 91.7 t -104.88 152.62 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 1.15 109.447 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.475 ' N ' HG11 ' A' ' 317' ' ' VAL . 31.4 mtp -102.42 146.16 28.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 1.72 109.444 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 322' ' ' SER . 34.4 mmtp -60.3 -73.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 2.26 109.509 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 50.1 m-20 60.7 23.97 13.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.89 109.406 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.58 36.39 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.547 -1.421 . . . . 1.16 109.547 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' SER . . . . . 0.501 ' HB3' ' NE2' ' A' ' 285' ' ' GLN . 3.0 m -137.25 146.64 45.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 1.83 109.466 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.81 12.74 2.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.885 . . . . 2.0 109.49 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.31 116.46 32.84 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.251 -0.906 . . . . 1.46 109.286 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.542 HG21 ' CE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -47.03 159.68 0.37 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.951 . . . . 1.08 109.537 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.47 ' HB3' HD22 ' A' ' 281' ' ' LEU . 34.1 Cg_endo -77.58 170.89 18.46 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.824 2.349 . . . . 0.31 110.673 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -106.12 122.05 45.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 1.1 109.36 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.5 ' CB ' ' CD2' ' A' ' 267' ' ' TYR . . . -100.75 148.96 24.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 1.11 109.511 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 46.3 p -138.96 126.77 22.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 1.04 109.521 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 14.5 t -85.16 124.18 31.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 1.06 109.433 179.917 169.863 -115.654 -93.017 104.194 2.02 104.192 134.376 52.279 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -123.86 114.34 19.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 1.74 109.474 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -153.62 91.14 0.13 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.559 -1.416 . . . . 2.38 109.559 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.261 -1.141 . . . . 4.53 109.491 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.74 ' O ' HG22 ' A' ' 247' ' ' THR . 97.8 m . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.519 -0.549 . . . . 4.36 109.519 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -136.14 145.47 17.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.527 -1.429 . . . . 1.71 109.527 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 11.6 p -109.77 170.2 8.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.264 -1.139 . . . . 0.94 109.473 179.988 52.279 134.376 -93.017 104.192 2.02 104.194 -115.654 169.863 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.622 ' O ' HG13 ' A' ' 269' ' ' VAL . 0.0 OUTLIER -149.28 175.02 11.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 1.31 109.656 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.649 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -132.8 117.02 28.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.785 -0.766 . . . . 0.78 109.577 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.12 115.1 27.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.62 109.429 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.645 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -108.14 128.89 55.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.59 109.454 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 160.58 29.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 1.05 109.47 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -100.49 120.86 40.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 2.04 109.502 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -92.05 -80.56 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.79 109.485 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -103.31 145.05 30.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.228 -0.92 . . . . 2.01 109.476 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -125.98 127.11 45.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 2.46 109.448 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -110.43 -170.78 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 1.03 109.477 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 13.5 m -100.74 3.17 42.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 1.67 109.537 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -133.86 7.3 3.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.915 . . . . 1.58 109.514 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 174.8 170.15 0.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.905 . . . . 2.11 109.448 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.513 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 51.9 p90 -144.39 134.02 23.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 1.23 109.453 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -80.0 154.86 27.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.71 109.464 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.699 HG11 ' CE1' ' A' ' 267' ' ' TYR . 3.3 t -133.86 155.38 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.47 109.536 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 3.4 m -126.2 93.14 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.42 109.437 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' TYR . . . . . 0.733 ' CE2' ' HB2' ' A' ' 328' ' ' ALA . 54.7 m-85 -91.44 136.22 33.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 1.27 109.486 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.493 ' HB3' HG23 ' A' ' 312' ' ' THR . 99.5 p -147.26 162.41 38.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 1.38 109.519 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.649 ' CG2' HG13 ' A' ' 251' ' ' VAL . 94.6 t -145.92 145.71 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.45 109.482 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.14 -173.52 2.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 1.48 109.438 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.5 -40.82 3.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.543 -1.423 . . . . 0.79 109.543 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 4.2 m -175.32 170.79 3.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -1.144 . . . . 1.37 109.441 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.5 p -101.88 -21.61 14.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 1.35 109.522 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.78 75.89 6.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.55 109.004 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.909 ' CE3' HG23 ' A' ' 277' ' ' VAL . 10.2 p-90 -128.53 170.89 12.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.37 109.656 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 331' ' ' ALA . 5.0 m -122.61 99.98 6.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.67 109.232 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.909 HG23 ' CE3' ' A' ' 275' ' ' TRP . 40.8 t -79.91 132.15 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.89 109.67 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 4.5 m-20 -124.35 114.94 20.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 1.74 109.232 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 21.1 mt -90.49 145.52 24.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.55 109.589 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -133.95 76.53 1.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.38 109.388 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.494 HD22 ' OE1' ' A' ' 285' ' ' GLN . 23.8 mt -59.9 168.81 1.66 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.928 . . . . 1.24 109.595 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -122.29 144.44 48.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 2.01 109.417 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.5 -114.92 3.94 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.553 -1.419 . . . . 1.1 109.553 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.82 18.5 3.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -1.113 . . . . 1.9 109.498 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.517 ' NE2' ' HB3' ' A' ' 322' ' ' SER . 68.1 mt-30 -50.18 153.18 1.51 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 1.58 109.443 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 44.9 p -140.84 165.66 26.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.64 109.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.621 HD12 HG11 ' A' ' 295' ' ' VAL . 16.8 mt -112.77 144.54 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.87 109.456 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.23 7.16 3.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 2.71 109.547 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.554 ' HB3' ' CB ' ' A' ' 316' ' ' THR . . . -151.57 152.67 33.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.925 . . . . 0.57 109.472 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 10.0 p -168.84 121.29 0.79 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 1.11 109.448 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.568 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 33.5 p90 -129.91 144.62 51.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.52 109.493 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 291' ' ' TRP . 0.3 OUTLIER 75.54 13.75 2.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 1.49 109.458 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 177.79 149.94 0.19 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.299 -0.876 . . . . 0.45 109.459 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -101.34 118.33 36.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 1.06 109.521 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.621 HG11 HD12 ' A' ' 287' ' ' ILE . 47.9 t -101.57 97.34 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.77 109.476 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 34.6 p -127.94 159.32 35.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 1.28 109.452 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 150.08 -174.02 29.62 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 1.65 109.545 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.62 163.92 37.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -1.179 . . . . 3.47 109.474 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 92.05 -153.02 21.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.557 -1.417 . . . . 2.74 109.557 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 52.7 m -92.32 9.45 33.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -1.149 . . . . 2.1 109.484 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.1 p -127.23 161.33 28.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 1.24 109.445 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.576 ' HD2' HG12 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -137.07 128.6 28.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.888 . . . . 2.26 109.465 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.4 m -86.39 143.71 27.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.82 109.49 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 295' ' ' VAL . 77.3 t -134.24 135.57 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.56 109.454 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 306' ' ' PRO . 72.7 p -139.56 157.3 70.53 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.73 109.461 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 305' ' ' THR . 35.6 Cg_endo -77.99 153.48 28.93 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.742 2.295 . . . . 0.81 110.43 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -122.04 17.33 10.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 1.3 109.501 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 85.3 44.07 6.36 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.56 -1.416 . . . . 1.58 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -49.13 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -1.165 . . . . 2.17 109.475 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 178.64 -165.63 34.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.566 -1.413 . . . . 1.22 109.566 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -115.94 10.0 15.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -1.146 . . . . 1.12 109.428 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.493 HG23 ' HB3' ' A' ' 268' ' ' SER . 23.4 m -120.75 109.68 15.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.68 109.47 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.738 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 38.9 p90 -127.03 160.53 30.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 1.33 109.485 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.568 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -124.37 157.61 18.74 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.548 -1.421 . . . . 0.32 109.548 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.19 148.69 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -1.137 . . . . 0.34 109.426 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.554 ' CB ' ' HB3' ' A' ' 289' ' ' ALA . 99.0 m -106.76 115.61 30.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.52 109.501 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.513 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 91.7 t -104.88 152.62 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.47 109.447 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 31.4 mtp -102.42 146.16 28.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 1.16 109.444 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 322' ' ' SER . 34.4 mmtp -60.3 -73.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 1.74 109.509 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 60.7 23.97 13.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.89 109.406 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.58 36.39 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.547 -1.421 . . . . 1.16 109.547 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' SER . . . . . 0.517 ' HB3' ' NE2' ' A' ' 285' ' ' GLN . 3.0 m -137.25 146.64 45.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 1.47 109.466 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.81 12.74 2.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.885 . . . . 1.65 109.49 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 324' ' ' THR . 1.0 OUTLIER -101.31 116.46 32.84 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.251 -0.906 . . . . 0.96 109.286 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.433 HG22 ' HE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -47.03 159.68 0.37 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.951 . . . . 0.35 109.537 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.443 ' HG2' ' OH ' ' A' ' 267' ' ' TYR . 34.1 Cg_endo -77.58 170.89 18.46 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.824 2.349 . . . . 0.27 110.673 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -106.12 122.05 45.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.58 109.36 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.733 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -100.75 148.96 24.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.4 109.511 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 46.3 p -138.96 126.77 22.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.4 109.521 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 14.5 t -85.16 124.18 31.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 1.06 109.433 179.917 169.863 -115.654 -93.017 104.194 2.02 104.192 134.376 52.279 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 276' ' ' THR . . . -123.86 114.34 19.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 1.29 109.474 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -153.62 91.14 0.13 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.559 -1.416 . . . . 2.38 109.559 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.261 -1.141 . . . . 4.2 109.491 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.74 ' O ' HG22 ' A' ' 247' ' ' THR . 97.8 m . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.519 -0.549 . . . . 4.36 109.519 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -136.14 145.47 17.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.527 -1.429 . . . . 1.71 109.527 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 11.6 p -109.77 170.2 8.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.264 -1.139 . . . . 0.94 109.473 179.988 52.279 134.376 -93.017 104.192 2.02 104.194 -115.654 169.863 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.622 ' O ' HG13 ' A' ' 269' ' ' VAL . 0.0 OUTLIER -149.28 175.02 11.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.275 -0.891 . . . . 1.31 109.656 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.649 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -132.8 117.02 28.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.785 -0.766 . . . . 0.78 109.577 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.12 115.1 27.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.62 109.429 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.645 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -108.14 128.89 55.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.59 109.454 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.84 160.58 29.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 1.05 109.47 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -100.49 120.86 40.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 2.04 109.502 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -92.05 -80.56 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.79 109.485 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -103.31 145.05 30.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.228 -0.92 . . . . 2.01 109.476 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -125.98 127.11 45.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 2.46 109.448 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -110.43 -170.78 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 1.03 109.477 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 13.5 m -100.74 3.17 42.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 1.67 109.537 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -133.86 7.3 3.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.915 . . . . 1.58 109.514 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 174.8 170.15 0.26 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.905 . . . . 2.11 109.448 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.513 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 51.9 p90 -144.39 134.02 23.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 1.23 109.453 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -80.0 154.86 27.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.71 109.464 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.699 HG11 ' CE1' ' A' ' 267' ' ' TYR . 3.3 t -133.86 155.38 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -0.943 . . . . 0.47 109.536 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 3.4 m -126.2 93.14 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -0.908 . . . . 0.42 109.437 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' TYR . . . . . 0.733 ' CE2' ' HB2' ' A' ' 328' ' ' ALA . 54.7 m-85 -91.44 136.22 33.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 1.27 109.486 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.493 ' HB3' HG23 ' A' ' 312' ' ' THR . 99.5 p -147.26 162.41 38.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 1.38 109.519 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.649 ' CG2' HG13 ' A' ' 251' ' ' VAL . 94.6 t -145.92 145.71 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.45 109.482 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.14 -173.52 2.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 1.48 109.438 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.5 -40.82 3.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.543 -1.423 . . . . 0.79 109.543 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 4.2 m -175.32 170.79 3.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -1.144 . . . . 1.37 109.441 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.5 p -101.88 -21.61 14.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 1.35 109.522 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.78 75.89 6.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.55 109.004 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.909 ' CE3' HG23 ' A' ' 277' ' ' VAL . 10.2 p-90 -128.53 170.89 12.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.37 109.656 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 331' ' ' ALA . 5.0 m -122.61 99.98 6.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -0.865 . . . . 0.67 109.232 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.909 HG23 ' CE3' ' A' ' 275' ' ' TRP . 40.8 t -79.91 132.15 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.89 109.67 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 4.5 m-20 -124.35 114.94 20.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 1.74 109.232 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 21.1 mt -90.49 145.52 24.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.55 109.589 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -133.95 76.53 1.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.38 109.388 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.494 HD22 ' OE1' ' A' ' 285' ' ' GLN . 23.8 mt -59.9 168.81 1.66 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.928 . . . . 1.24 109.595 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -122.29 144.44 48.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 2.01 109.417 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.5 -114.92 3.94 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.553 -1.419 . . . . 1.1 109.553 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.82 18.5 3.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -1.113 . . . . 1.9 109.498 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.517 ' NE2' ' HB3' ' A' ' 322' ' ' SER . 68.1 mt-30 -50.18 153.18 1.51 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 1.58 109.443 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 44.9 p -140.84 165.66 26.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.64 109.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.621 HD12 HG11 ' A' ' 295' ' ' VAL . 16.8 mt -112.77 144.54 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.87 109.456 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.23 7.16 3.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 2.71 109.547 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.554 ' HB3' ' CB ' ' A' ' 316' ' ' THR . . . -151.57 152.67 33.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.925 . . . . 0.57 109.472 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 10.0 p -168.84 121.29 0.79 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 1.11 109.448 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.568 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 33.5 p90 -129.91 144.62 51.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.52 109.493 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 291' ' ' TRP . 0.3 OUTLIER 75.54 13.75 2.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 1.49 109.458 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 177.79 149.94 0.19 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.299 -0.876 . . . . 0.45 109.459 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -101.34 118.33 36.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 1.06 109.521 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.621 HG11 HD12 ' A' ' 287' ' ' ILE . 47.9 t -101.57 97.34 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.77 109.476 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 34.6 p -127.94 159.32 35.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 1.28 109.452 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 150.08 -174.02 29.62 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.545 -1.422 . . . . 1.65 109.545 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.62 163.92 37.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -1.179 . . . . 3.47 109.474 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 92.05 -153.02 21.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.557 -1.417 . . . . 2.74 109.557 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 52.7 m -92.32 9.45 33.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -1.149 . . . . 2.1 109.484 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.1 p -127.23 161.33 28.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 1.24 109.445 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.576 ' HD2' HG12 ' A' ' 295' ' ' VAL . 0.0 OUTLIER -137.07 128.6 28.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.888 . . . . 2.26 109.465 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.4 m -86.39 143.71 27.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.82 109.49 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 295' ' ' VAL . 77.3 t -134.24 135.57 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.56 109.454 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 306' ' ' PRO . 72.7 p -139.56 157.3 70.53 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.73 109.461 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 305' ' ' THR . 35.6 Cg_endo -77.99 153.48 28.93 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.742 2.295 . . . . 0.81 110.43 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -122.04 17.33 10.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 1.3 109.501 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 85.3 44.07 6.36 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.56 -1.416 . . . . 1.58 109.56 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -49.13 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -1.165 . . . . 2.17 109.475 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 178.64 -165.63 34.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.566 -1.413 . . . . 1.22 109.566 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -115.94 10.0 15.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -1.146 . . . . 1.12 109.428 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.493 HG23 ' HB3' ' A' ' 268' ' ' SER . 23.4 m -120.75 109.68 15.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.68 109.47 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.738 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 38.9 p90 -127.03 160.53 30.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 1.33 109.485 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.568 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -124.37 157.61 18.74 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.548 -1.421 . . . . 0.32 109.548 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.19 148.69 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -1.137 . . . . 0.34 109.426 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.554 ' CB ' ' HB3' ' A' ' 289' ' ' ALA . 99.0 m -106.76 115.61 30.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.52 109.501 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.513 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 91.7 t -104.88 152.62 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.47 109.447 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 31.4 mtp -102.42 146.16 28.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 1.16 109.444 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 322' ' ' SER . 34.4 mmtp -60.3 -73.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 1.74 109.509 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 60.7 23.97 13.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.89 109.406 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.58 36.39 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.547 -1.421 . . . . 1.16 109.547 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . 0.517 ' HB3' ' NE2' ' A' ' 285' ' ' GLN . 3.0 m -137.25 146.64 45.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -1.148 . . . . 1.47 109.466 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.81 12.74 2.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.885 . . . . 1.65 109.49 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 324' ' ' THR . 1.0 OUTLIER -101.31 116.46 32.84 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.251 -0.906 . . . . 0.96 109.286 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.433 HG22 ' HE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -47.03 159.68 0.37 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.951 . . . . 0.35 109.537 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.443 ' HG2' ' OH ' ' A' ' 267' ' ' TYR . 34.1 Cg_endo -77.58 170.89 18.46 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.824 2.349 . . . . 0.27 110.673 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -106.12 122.05 45.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.58 109.36 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.733 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -100.75 148.96 24.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.4 109.511 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 46.3 p -138.96 126.77 22.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.4 109.521 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 275' ' ' TRP . 14.5 t -85.16 124.18 31.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 1.06 109.433 179.917 169.863 -115.654 -93.017 104.194 2.02 104.192 134.376 52.279 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 276' ' ' THR . . . -123.86 114.34 19.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 1.29 109.474 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -153.62 91.14 0.13 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.559 -1.416 . . . . 2.38 109.559 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.261 -1.141 . . . . 4.2 109.491 -179.963 . . . . . . . . 1 1 . 1 stop_ save_